4//SEC Filing
THERASENSE INC 4
Accession 0000950005-04-000345
CIK 0001073695operating
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 2:09 PM ET
Size
22.9 KB
Accession
0000950005-04-000345
Insider Transaction Report
Form 4
THERASENSE INCTHER
MOMSEN ROBERT R
Director10% Owner
Transactions
- Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−101,494$2,740,338→ 0 total(indirect: By: InterWest Investors VI, LP) - Disposition to Issuer
NQ option (right to buy)
2004-04-05$5.75/sh−5,000$28,750→ 0 totalExercise: $21.25Exp: 2012-04-18→ Common (5,000 underlying) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−27,647$746,469→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−1,000$27,000→ 0 total(indirect: By: Robert Momsen Custodian FBO Paige Momsen under CA uniform TFR to Minor) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−175,000$4,725,000→ 0 total(indirect: By: InterWest Venture Mgmt Co. PSRP FBO Robert R. Momsen) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−100,306$2,708,262→ 0 total(indirect: By: InterWest Partners V, LP) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−3,237,103$87,401,781→ 0 total(indirect: By: InterWest Partners VI, LP) - Disposition to Issuer
NQ option (right to buy)
2004-04-05$22.00/sh−30,000$660,000→ 0 totalExercise: $5.00Exp: 2010-09-28→ Common (30,000 underlying)
Footnotes (6)
- [F1]InterWest Management Partners VI, LLC has sole voting and investment control over the shares held by InterWest Partners VI, L.P. and InterWest Investors VI, L.P. The reporting person is a managing director of InterWest Management Partners VI, LLC, and shares voting and investment control of the shares held by the fund. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, or otherwise, the reporting person is the beneficial owner of all of the equity securities covered by this statement.
- [F2]InterWest Management Partners V, L.P. has sole voting and investment control over the shares held by InterWest Partners V, L.P. The reporting person is a general partner of InterWest Management Partners V, L.P., and shares voting and investment control of the shares held by the fund. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, or otherwise, the reporting person is the beneficial owner of all of the equity securities covered by this statement.
- [F3]The shares are held in the name of The Momsen Living Trust U/A/D 1-5-95 of which Robert Momsen is the Trustee.
- [F4]Disposed of pursuant to a merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F5]This option vests over a three year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
- [F6]This option vests on the one-year anniversary from the date of grant and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 2:09 PM ET
- Size
- 22.9 KB